Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding

Background: Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients and has also been used for a diverse range of off-label indications in the context of massive uncontrolled blood loss; however, no convincing evidence exists regarding th...

Full description

Bibliographic Details
Main Authors: Zhi-gang Chang MD, PhD, Xin Chu MD, Wen Chen MD, Jun-hua Hu MD, Ji-wu Gong MD, Da-dong Liu MD, Qing He MD, Zhe Feng MD, Shi-rou Xiao MD, Ya-lin Liu MD
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/1559325820969569

Similar Items

Similar Items